Sargent Investment Group, LLC Merck & Co., Inc. Transaction History

Sargent Investment Group, LLC

$546 Million
Q3 2024

A detailed history of Sargent Investment Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sargent Investment Group, LLC holds 12,470 shares of MRK stock, worth $1.25 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

12,470

Previous 14,085 11.47%

Holding current value

$1.25 Million

Previous $1.74 Million 18.76%

% of portfolio

0.26%

Previous 0.36%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$111.15 - $128.97 $179,507 - $208,286	-1,615 Reduced 11.47%	12,470 $1.42 Million
Q2 2024 Aug 09, 2024	BUY	$123.8 - $132.96 $164,406 - $176,570	1,328 Added 10.41%	14,085 $1.74 Million
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $181,863 - $211,911	-1,606 Reduced 11.18%	12,757 $1.68 Million
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $7,313 - $7,958	73 Added 0.51%	14,363 $1.57 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $233,902 - $259,757	2,272 Added 18.9%	14,290 $1.47 Million
Q2 2023 Jul 31, 2023	BUY	$108.61 - $118.38 $64,079 - $69,844	590 Added 5.16%	12,018 $1.39 Million
Q1 2023 May 02, 2023	BUY	$102.94 - $114.86 $18,940 - $21,134	184 Added 1.64%	11,428 $1.22 Million
Q4 2022 Jan 31, 2023	BUY	$87.44 - $112.11 $130,810 - $167,716	1,496 Added 15.35%	11,244 $1.25 Million
Q3 2022 Oct 26, 2022	BUY	$84.53 - $94.96 $21,132 - $23,740	250 Added 2.63%	9,748 $852,000
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $20,961 - $26,256	-290 Reduced 2.96%	9,498 $728,000
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $4,300 - $4,729	60 Added 0.62%	9,788 $735,000
Q2 2021 Aug 05, 2021	SELL	$70.31 - $77.77 $31,991 - $35,385	-455 Reduced 4.47%	9,728 $757,000
Q1 2021 May 04, 2021	BUY	$68.86 - $81.11 $125,669 - $148,025	1,825 Added 21.84%	10,183 $785,000
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $48,157 - $53,445	671 Added 8.73%	8,358 $684,000
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $1,244 - $1,410	-17 Reduced 0.22%	7,687 $638,000
Q1 2020 May 12, 2020	BUY	$63.36 - $87.82 $6,209 - $8,606	98 Added 1.29%	7,704 $593,000
Q4 2019 Jan 30, 2020	BUY	$77.58 - $87.54 $48,952 - $55,237	631 Added 9.05%	7,606 $692,000
Q3 2019 Oct 29, 2019	SELL	$76.08 - $82.93 $989 - $1,078	-13 Reduced 0.19%	6,975 $587,000
Q2 2019 Aug 12, 2019	SELL	$69.84 - $81.59 $66,348 - $77,510	-950 Reduced 11.97%	6,988 $586,000
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $67,492 - $76,979	970 Added 13.92%	7,938 $660,000
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $454,592 - $527,547	6,968 New	6,968 $532,000

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Account

Sargent Investment Group, LLC Merck & Co., Inc. Transaction History